Teleman Dan Benjamin
- SEC CIK
- 0002122500
In the past year, 3 open-market purchase filings worth $61.8K and no sales.
Current role at each company
- NSRX Nasus Pharma LtdChief Executive Officeras of Jul 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $61.8K
- 3 filings
- Sold
- –
- 0 filings
- Net
- +$61.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Teleman Dan Benjamin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | Jun 17 | 5 days | Teleman Dan BenjaminChief Executive Officer | PPurchase | +6.55K | $3.10 | +$20.3K | +4.2%163.5K after | |
| Apr 22, 2026 (view filing) | Apr 22 | Same day | Teleman Dan BenjaminChief Executive Officer | PPurchase | +2.90K | $3.76 | +$10.9K | +1.9%157.0K after | |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Teleman Dan BenjaminChief Executive Officer | PPurchase | +15.0K | $2.04 | +$30.6K | +240.2%21.2K after |